0001140361-24-003434.txt : 20240123
0001140361-24-003434.hdr.sgml : 20240123
20240123163338
ACCESSION NUMBER: 0001140361-24-003434
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shepard Kirk V.
CENTRAL INDEX KEY: 0002009007
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 24553051
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
X0508
4
2024-01-22
0001472091
PDS Biotechnology Corp
PDSB
0002009007
Shepard Kirk V.
C/O PDS BIOTECHNOLOGY CORPORATION
303A COLLEGE ROAD EAST
PRINCETON
NJ
08540
true
Chief Medical Officer
false
Employee Stock Option (Right to Buy)
4.49
2024-01-22
4
A
0
200000
0
A
2034-01-22
Common Stock
200000
200000
D
The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 22,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/ Kirk V. Shepard
2024-01-23